Pan-PPAR Agonist, Bezafibrate, Restores Angiogenesis in Hindlimb Ischemia in Normal and Diabetic Rats

<table>Representative photographs of immunohistochemical staining (<svg height="11.125" id="M51" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 34.575001 11.125" width="34.575001" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M528 54l-36 -38l-198 201l-198 -201l-36 38l197 200l-197 201l36 38l198 -202l198 202l36 -38l-197 -201z" id="xD7"></path></g><g transform="matrix(.017,-0,0,-.017,10.041,10.862)"><use xlink:href="#x34"></use></g><g transform="matrix(.017,-0,0,-.017,18.2,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,26.36,10.862)"><use xlink:href="#x30"></use></g>
</svg>) with anti-CD31 monoclonal antibody in experimental groups. Arrows indicates CD31-positive cells.</table>

International Journal of Peptides

fig4

Figure 4

Figure 4: Pan-PPAR Agonist, Bezafibrate, Restores Angiogenesis in Hindlimb Ischemia in Normal and Diabetic Rats 